Ipca Laboratories consolidated net profit declines 19.28% in the March 2022 quarter

24 May 2022 , 02:39 PM

Net profit of Ipca Laboratories declined 19.28% to Rs 130.23 crore in the quarter ended March 2022 as against Rs 161.34 crore during the previous quarter ended March 2021. Sales rose 15.65% to Rs 1289.10 crore in the quarter ended March 2022 as against Rs 1114.66 crore during the previous quarter ended March 2021. For the full year,net profit declined 22.45% to Rs 884.08 crore in the year ended March 2022 as against Rs 1140.01 crore during the previous year ended March 2021. Sales rose 7.56% to Rs 5829.79 crore in the year ended March 2022 as against Rs 5419.99 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	1289.10	1114.66	16	5829.79	5419.99	8
OPM %	17.01	20.54	–	22.46	28.49	–
PBDT	230.49	247.13	-7	1368.14	1598.15	-14
PBT	169.55	194.63	-13	1135.72	1388.98	-18
NP	130.23	161.34	-19	884.08	1140.01	-22

Powered by Capital Market – Live News